Oncimmune Holdings PLC (LON:ONC) passed above its fifty day moving average during trading on Wednesday . The stock has a fifty day moving average of $145.16 and traded as high as $151.90. Oncimmune shares last traded at $151.50, with a volume of 5,797 shares changing hands.
Separately, FinnCap restated a “corporate” rating on shares of Oncimmune in a research report on Monday, July 27th.
The company has a current ratio of 3.91, a quick ratio of 3.84 and a debt-to-equity ratio of 375.32. The company has a fifty day moving average price of GBX 145.16 and a two-hundred day moving average price of GBX 106.18. The firm has a market capitalization of $96.27 million and a price-to-earnings ratio of -9.47.
About Oncimmune (LON:ONC)
Oncimmune Holdings Plc, an early cancer detection company, develops and commercializes products to diagnose cancer in the United Kingdom and North America. The company engages in the development of autoantibody based platform to allow cancer detection to a range of solid cancer tumor types. It offers EarlyCDT-Lung, a blood test, which is ordered by a doctor to aid in the risk assessment and early detection of lung cancer in high-risk patients and to stratify indeterminate pulmonary nodules for the risk of malignancy.
Read More: What is a put option?
Receive News & Ratings for Oncimmune Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oncimmune and related companies with MarketBeat.com's FREE daily email newsletter.